Concomitant Administration of Interleukin-2 During Therapeutic Vaccinations Against Cancer: The Good, the Bad, or the Evil?-Reference-Cited by-同舟云学术

Concomitant Administration of Interleukin-2 During Therapeutic Vaccinations Against Cancer: The Good, the Bad, or the Evil?

Published:2005-08-01 Issue:22 Volume:23 Page:5265-5267
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Andersen Mads Hald¹,Reker Sine¹,thor Stratem Per¹,Gehl Julie²,Geertsen Poul²,Becker Jürgen C.³

Affiliation:

1. Tumor Immunology Group, Danish Cancer Society, Copenhagen, Denmark

2. Department of Oncology, Herlev University Hospital, Herlev, Denmark

3. Department of Dermatology, University of Würzburg, Würzburg, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.00.9837

Reference10 articles.

1. Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule

2. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

3. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

4. Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes

5. Andersen MH, Ostergaard Pedersen L, Becker JC, et al: Identification of a cytotoxic T lymphocyte response to the apoptose inhibitor protein Survivin in cancer patients. Cancer Res 61:869,2001-872,

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditional ligands for A sian HLA variants facilitate the definition of CD 8 + T ‐cell responses in acute and chronic viral diseases;European Journal of Immunology;2013-02-14

2. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity;Radiology and Oncology;2012-10-01

3. Gene Expression Signatures of Interleukin-2 In Vivo and In Vitro and Their Relation to Anticancer Therapy;Critical Reviews™ in Immunology;2007

4. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy;Advanced Drug Delivery Reviews;2006-10

5. Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients;Journal of Translational Medicine;2006-06